DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection

This publication has 23 references indexed in Scilit:

• Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized, Controlled Trial
  Obstetrical & Gynecological Survey, 2005
• Prevention of cervical cancer through papillomavirus vaccination
  Nature Reviews Immunology, 2004
• Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
  The Journal of Immunology, 2002
• Papillomaviruses and cancer: from basic studies to clinical application
  Nature Reviews Cancer, 2002
• The Human Papillomavirus E6 protein and its contribution to malignant progression
  Oncogene, 2001
• Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to Antigen
  Journal of Virology, 2001
• Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
  Gene Therapy, 2001
• Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
  Gene Therapy, 2000
• Human papillomavirus and other risk factors for cervical cancer
  Biomedicine & Pharmacotherapy, 1997
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
  European Journal of Immunology, 1993